UPC Analytics
ENDE
Overview · Filed: Jul 31, 2025

UPC_CFI_697/2025

Methods of Using Sustained Release Aminopyridine Compositions

Provisional measuresProvisional MeasuresParis LDProvisional measuresWritten Phase
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Merz Pharmaceuticals LLC, Merz Therapeutics GmbH, Merz Pharma FrancevViatris Santé

Respondents

  • Viatris Santé
Judges

French-seated division — individual judges anonymized.

  • Panel member (anonymized)
  • Panel member (anonymized)
  • Panel member (anonymized)
  • Panel member (anonymized)
Patents
  • EP2377536
CPC codes: A61P43/00, A61P19/08, A61K31/435, A61P25/28, A61K9/20, A61K31/44, A61P21/00, A61P17/02, A61K31/4409, A61P25/00

Sector: Pharmaceutical & Medical

Outcome
—
Filed: Jul 31, 2025
First decided: Nov 21, 2025
Language: English
Open on UPC Registry